PressOctober 19, 2021 Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug Delivery System
PressOctober 18, 2021 Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
PressOctober 15, 2021 Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy
PressOctober 12, 2021 Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
PressOctober 11, 2021 Atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression
PressOctober 8, 2021 Tryp Therapeutics To Collaborate With Researchers at The University of Wisconsin-Madison
PressOctober 7, 2021 Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial
PressOctober 6, 2021 PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease
PressOctober 5, 2021 Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD
PressOctober 4, 2021 Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development
PressSeptember 29, 2021 HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations
PressSeptember 28, 2021 BetterLife Pharma Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile
PressSeptember 27, 2021 MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy
PressSeptember 27, 2021 Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
PressSeptember 24, 2021 MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
PressSeptember 20, 2021 Mindset Pharma Announces Further Preclinical Results for its 5-MeO-DMT-Inspired Drug Candidate.
PressSeptember 20, 2021 Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States
